-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Pfizer CEO says the drugmaker is prepared to shift manufacturing to the US amid tariff threats
Pfizer (PFE) CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if necessary, as the Trump administration considers imposing tariffs on pharmaceuticals. Read more...
Pfizer (PFE) CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if necessary, as the Trump administration considers imposing tariffs on pharmaceuticals.
